Analyst Ratings for Belite Bio, Inc, ADR (BLTE)
BLTE Rating Summary
BLTE Price Target Summary
- Highest: $266.00 (Cantor Fitzgerald)
- Lowest: $140.00 (Leerink Partners)
- Average: $197.75
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$197.75 (+14.1%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$197.75 (+14.1%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/26/2026 | BofA Securities | Ebrahim Poonawala | New Coverage | Buy (N/A) |
195.00 (N/A) |
164.58 (173.30) |
5.3% | Details |
| 1/6/2026 | Morgan Stanley » Updated 3/3/2026 |
Judah Frommer | New Coverage | Overweight (N/A) |
201.00 (191.00) |
159.27 (173.30) |
8.81% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
